相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis
Rasmus Siersbaek et al.
CANCER CELL (2020)
Interleukin-6 Expression by Hypothalamic Microglia in Multiple Inflammatory Contexts: A Systematic Review
Vanessa C. D. Bobbo et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map
Jennifer Huynh et al.
NATURE REVIEWS CANCER (2019)
BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer
Chun Gong et al.
CLINICAL CANCER RESEARCH (2018)
Hormone receptor-positive, HER2-negative metastatic breast cancer: redrawing the lines
A. Matutino et al.
CURRENT ONCOLOGY (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Signaling pathways and steroid receptors modulating estrogen receptor a function in breast cancer
Rasmus Siersbaek et al.
GENES & DEVELOPMENT (2018)
The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer
Cesidio Giuliani et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Interlekukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Supressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer
Mengmeng Jiang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Ramona Crescenzo et al.
CANCER CELL (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Versatile functions for IL-6 in metabolism and cancer
Jan Mauer et al.
TRENDS IN IMMUNOLOGY (2015)
Molecular mechanisms of tamoxifen-associated endometrial cancer
Rong Hu et al.
ONCOLOGY LETTERS (2015)
Cisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cells
Wei-Hsiu Liu et al.
ONCOTARGET (2015)
Tocilizumab, A Humanized Anti-IL-6R Antibody, as an Emerging Therapeutic Option for Rheumatoid Arthritis: Molecular and Cellular Mechanistic Insights
Misato Hashizume et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2015)
The Eukaryotic Promoter Database: expansion of EPDnew and new promoter analysis tools
Ren Dreos et al.
NUCLEIC ACIDS RESEARCH (2015)
IL-6 in Inflammation, Immunity, and Disease
Toshio Tanaka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer
Sandra Van Schaeybroeck et al.
CELL REPORTS (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
SpliceArray Profiling of Breast Cancer Reveals a Novel Variant of NCOR2/SMRT That Is Associated with Tamoxifen Resistance and Control of ERα Transcriptional Activity
Luduo Zhang et al.
CANCER RESEARCH (2013)
Emerging roles of the corepressors NCoR1 and SMRT in homeostasis
Adrienne Mottis et al.
GENES & DEVELOPMENT (2013)
Transcription factor co-repressors in cancer biology: roles and targeting
Sebastiano Battaglia et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Tamoxifen stimulates the growth of cyclin D1 - Overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3
Yuki Ishii et al.
CANCER RESEARCH (2008)
The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor α transcriptional activity
Theresa J. Peterson et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines
Lee-Jun C. Wong et al.
BMC CANCER (2006)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients
T Bachelot et al.
BRITISH JOURNAL OF CANCER (2003)
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
R Salgado et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
IκBβ and p65 regulate the cytoplasmic shuttling of nuclear corepressors:: Cross-talk between notch and NFκB pathways
L Espinosa et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
